En este artculo, compartir informacin clara y prctica, basada en mi experiencia clnica y en estudios mdicos, para ayudarte a tomar decisiones informadas sobre este medicamento
Since then, several others have followed, including dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), semaglutide (Ozempic, Wegovy), and the latest FDA-approved medication, tirzepatide (Mounjaro, Zepbound)
"ATTAINMAINTAIN showed that orforglipron, a once-daily oral GLP-1, helped people maintain the weight they worked hard to lose." This data provides the first robust, Phase 3 evidence that an oral "step-down" or "switch" strategy is not just feasible but effective, offering a new pathway for the long-term management of obesity
Despite the great therapeutic potential of GLP-1R agonists, some challenges and shortcomings remain
The Role of Dose Consistency and Timing Maintaining a consistent injection schedule is critical for sustained weight loss on GLP-1 therapy
Step 1: Talk to your healthcare provider first Your provider will review your current dose, your health history, and your goals before advising on next steps